Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis. [PDF]
Guo P, Yu X, Wei X, Xiong X, Jiang J.
europepmc +1 more source
Ezetimibe vs Inclisiran in Coronary Artery Disease and Hyperlipidemia: A Propensity-Matched Analysis. [PDF]
Akbar UA +7 more
europepmc +1 more source
Utilizing Electronic Health Record-Based Alerts to Increase Prescription of Lipid-Lowering Therapies in Patients Admitted With Acute Coronary Syndromes. [PDF]
Rowland S +4 more
europepmc +1 more source
Impact of Age on Lipid-Lowering Therapy Prescriptions and LDL-Cholesterol Control: Insights from the PORTRAIT-DYS Study. [PDF]
Gavina C +8 more
europepmc +1 more source
Physician Disagreement With Guidelines as a Critical Barrier to Achieving LDL-C Targets in Very High-Risk Patients: An Implementation Science Study. [PDF]
Cho KH +15 more
europepmc +1 more source
Jacques Donzé +2 more
openaire +1 more source
Combination Lipid-Lowering Therapy After ACS: Should this be the New Standard of Care? [PDF]
Brandts J, Marx N.
europepmc +1 more source
Cardiovascular outcomes and adverse drug reactions associated with the use of ezetimibe in combination with a statin in diabetes mellitus patients with higher risk for myocardial infarction: a meta-analysis. [PDF]
Zhou Y, Jin J.
europepmc +1 more source
Computational Prediction of Deleterious SNPs in the GALNS Gene Implicated in Morquio A Syndrome (MPS IVA). [PDF]
Priya M +4 more
europepmc +1 more source
Choosing the Right Non-Statin Therapy for the Right Patient - How To Sequence Advanced Lipid-Lowering Therapies. [PDF]
Katzmann JL, Laufs U.
europepmc +1 more source

